Synexa Joins CEPI in advancing global epidemic preparedness and response
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
Synexa joins CEPI’s esteemed Central Lab Network to improve global epidemic preparedness
Brexit had a negative impact on NHS staff shortages and worsened the workforce crisis
The partnership will capitalize on the combined capabilities of the two organizations
The news on a shift in its focus comes after the refinement of Bayer’s early innovation framework
The R&D Center significantly increases Siegfried’s R&D capacity to drive further growth
FDA’s NME approvals declined substantially in 2022, causing overall New Drug Application (NDA) approvals to drop
The milestone of operating continuously a very complex system for over two years has demonstrated the effectiveness of integrated laboratory automation solutions
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
Ayurveda OPD will be established in 10 ECHS Polyclinic/Dispensaries in various regions of India to cover all ECHS members on a voluntary basis
Women of all ages will get round-the-clock access to comprehensive treatment
Subscribe To Our Newsletter & Stay Updated